The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis

Renal Failure

Volumn 29, Issue 7, 2007, Pages 779-784

  Paydas, Saime ^a   Balal, Mustafa ^a   Tanriverdi, Kahraman ^a   Sertdemir, Yasar ^a   Baslamisli, Fikri ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Glomerulonephritis; PBMNC VEGF mRNA expression; Serum and urinary VEGF

Indexed keywords

CREATININE; MESSENGER RNA; PROTEIN; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULONEPHRITIS; GLOMERULOPATHY; GLOMERULOSCLEROSIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEINURIA; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINALYSIS; URINE LEVEL;

ADOLESCENT; ADULT; AGED; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MALE; MIDDLE AGED; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36248971796     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701540136     Document Type: Article

References (12)

1. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65:2003-2017.
2. Klanke B, Simon M, Röckl W, et al. Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney. Nephrol Dial Transplant. 1998;13:875-885.
3. Nitta K, Uchida K, Honda K, et al. Serum vascular endothelial growth factor concentration in rapidly progressive glomerulonephritis. Nephron. 1998;80:357-358.
4. Nitta K, Uchida K, Kimata N, et al. Increased serum levels of vascular endothelial growth factor in human crescentic glomerulonephritis. Clin Nephrol. 1999;52:76-82.
5. Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimalchange nephrotic syndrome. Clin Nephrol. 2001;55:269-274.
6. Soubrier M, Sauron C, Souweine B, et al. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Am J Kidney Dis. 1999;34:633-638.
7. Cheong HI, Lee JH, Hahn H, et al. Circulating VEGF and TGF-beta1 in children with idiopathic nephrotic syndrome. J Nephrol. 2001;14:263-269.
8. Wasada T, Kawahara R, Katsumori K, et al. Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking. Metabolism. 1998;47:27-30.
9. Cha DR, Kim NH, Yoon JW, et al. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int. 2000;58 (Suppl. 77):S104-S112.
10. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol. 1996;7:661-666.
11. Honkanen EO, Teppo AM, Gronhagen-Riska C. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int. 2000:57:2343-2349.
12. Gröne HJ, Simon M, Gröne EF. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts. J Pathol. 1995;177:259-267.